GSA Capital Partners’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,729
| Closed | -$66K | – | 2106 |
|
|
2024
Q2 | $66K | Buy |
28,729
+17,955
| +167% | +$41.2K | ﹤0.01% | 1556 |
|
|
2024
Q1 | $47K | Sell |
10,774
-15,243
| -59% | -$66.5K | ﹤0.01% | 1536 |
|
|
2023
Q4 | $79K | Buy |
26,017
+6,651
| +34% | +$20.2K | 0.01% | 1409 |
|
|
2023
Q3 | $28K | Sell |
19,366
-246,651
| -93% | -$357K | ﹤0.01% | 1433 |
|
|
2023
Q2 | $662K | Buy |
+266,017
| New | +$662K | 0.07% | 566 |
|
|
2022
Q4 | – | Sell |
-11,042
| Closed | -$138K | – | 1983 |
|
|
2022
Q3 | $138K | Sell |
11,042
-192,503
| -95% | -$2.41M | 0.02% | 1312 |
|
|
2022
Q2 | $1.01M | Buy |
+203,545
| New | +$1.01M | 0.15% | 142 |
|
|
2020
Q4 | – | Sell |
-35,742
| Closed | -$413K | – | 1680 |
|
|
2020
Q3 | $413K | Buy |
+35,742
| New | +$413K | 0.07% | 513 |
|
|
2020
Q2 | – | Sell |
-25,428
| Closed | -$280K | – | 1207 |
|
|
2020
Q1 | $280K | Buy |
+25,428
| New | +$280K | 0.07% | 529 |
|